That's essential, because the method a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and be effective. In other words, we need to know how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error procedure (jeff brown 2021 stock picks). However now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was a breakthrough almost no one discovered. However it's going to have profound ramifications for treating disease. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be plenty of financial investment chances in this area, too. Moving topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown prediction for 2021). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it pulled back maybe substantially before going higher - jeff brown 2021 stock predictions. I've been covering bitcoin for a long time now. Among the very first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were primarily informing readers. However that's not the big concern any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a relied on 170-year-old institution. So believe about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. black sea. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are numerous great private business on the brink of striking the public markets And I have actually been dealing with a new way for you to invest even before these business go public.
This chance has actually been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to reserve your area totally free.
Emma Walsh here, handling editor of the Journal. Routine Journal readers know that tech isn't our normal beat (genetic sequencer stock jeff brown). And when it concerns tech investing, we leave it to the experts. Thankfully, we have numerous such experts in our Rolodex. Our coworker Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing professionals we know (self-driving cars). In reality, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and forecast what's simply around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and far more. These trends are experiencing exponential development and producing extraordinary chances for investors. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. white house. But despite what numerous readers may think, this is a trend that's simply getting started. Even though the COVID-19 pandemic disrupted supply chains last year, an excellent 250 million 5G-enabled devices were still offered.
And all of this ultimately caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (brownstone research). Losing 2 months of manufacturing and sales truly impacts the number of 5G gadgets are sold in the calendar year. When you consider all of that, selling 250 million units is remarkable. More importantly, the delays triggered by the pandemic created a lots of pent-up need. Which need is now going to be pressed into 2021. In fact, I forecast that more than 500 million 5G devices will be shipped in 2021 - white house. Which's not my only 5G forecast When I have actually spoken about 5G in the past, I've described its 3 different stages.
In Phase Two, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Phase Three, 5G services start to be provided (self-driving cars). That's when we begin to see applications running on 5G networks. Think about things like huge multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Stage 3 by this summertime. This begins something of a virtuous cycle: Many people don't truly care about the technology. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open up a suite of amazing applications: self-driving cars, the Web of Things, robotic surgery, and more. All of these technologies need 5G. The investment opportunities moving forward will be massive. Stepping far from 5G, the next crucial innovation I foresee in 2021 is CRISPR genetic modifying. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it is among the most amazing developments in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software.
The program can crash or not operate properly. CRISPR utilizes a comparable concept however with our genetic code. "Typos" in our genome can result in illness. CRISPR can fix these "typos." For years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And throughout that time, there were actually just 3 business operating in this area. However things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're treating illness and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and providing incredible returns. This whole industry is successfully a greenfield chance.
There's space for lots of companies to exist in this area. jeff brown biotech stock pick for 2020. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or 3 more genetic editing companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software application can accurately forecast the folding of a protein based exclusively on its amino acid sequence with 92. 4% precision. That is essential due to the fact that the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been an experimental process. However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much easier to create drugs that do what they're developed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however a number of drug therapies produced utilizing this technology. This was among those developments that practically no one noticed. However it's going to have profound ramifications for curing disease. And, obviously, there will be plenty of financial investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps significantly prior to going greater. I have actually been covering bitcoin for a long period of time now. One of the very first research study reports I ever released was on bitcoin - self-driving cars. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my suggestion. However at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. jeff brown 1 biotech. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the details depends on date as of February 2021, but we might not independently verify this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an exact figure at this moment. Brown is best known for his sage-like capability to choose winning innovation stocks. He invested more than 25 years researching technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an excellent point of view on the marketplace. He's constantly on the hunt for new opportunities, and he shares much of his best picks in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an exceptional track record as a stock-picker, and he successfully forecasted some of the most significant financial events of the previous twenty years. Although he does not appear to launch his choices to the public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it right every time, but Jeff Brown's precise forecasts have actually earned him legions of dedicated followers. That states a lot about his capability. The Near Future Report is published by Brownstone Research study, a prominent monetary research study publisher. Brownstone Research provides numerous research services with a wide range of specializations - jeff brown genetic sequencer stock.
The business is likewise affiliated with Bonner & Partners, another well-respected research study publisher - what is the legacy report predicting. On its website, Brownstone states its objective is to offer retail investors with professional-grade research study: "For too long, the very best investment research study has actually not been available to individual investors. It has been usually booked for investment banks, hedge funds, personal equity, and high-net-worth clients. brownstone research stock. The mission of Brownstone Research is to make that sort of exclusive research available to any investors looking to get an edge in the marketplaces. The objective is basic to provide distinct and lucrative investment research discovered nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise serves as the company's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After years of steady success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a home name throughout most of America. If you know even a bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. future report review. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In fact, Brown thinks S.A.V. bleeding edge. might be "the most significant trend of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying 2 advanced innovations: synthetic intelligence and electrical cars. Musk hopes the combination will help him develop the very first fully-autonomous, self-driving automobiles ever. It's nothing brief of the automobile industry's Holy Grail. As you understand, electrical vehicles and self-driving vehicle stocks have been huge this year, but the Wall Street maker has been big on hype without much tangible outcome. In spite of a drastic increase in competition over the past few years, Brown still believes Musk has the very best opportunity of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. means Shared Autonomous Car, and it could be the future of transport. Basically, this innovation would permit you to rent out your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You merely leave the car and press a button on an app that informs the cars and truck to "join the fleet." Next thing you understand, you're relaxing on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a large portion of the profits. It sounds crazy, however it might be closed than you think.